INTERVIEW ON THE PRICE OF BUSINESS SHOW, MEDIA PARTNER OF THIS SITE.

Recently Kevin Price, Host of the nationally syndicated Price of Business Show, welcomed Dr. Terry McIvor to provide another commentary in a series.

The Dr. Terry McIvor Commentaries

Researchers at the Salk Institute for Biological Studies, led by Sung Han, have identified the Lateral Parabrachial Nucleus (LPBN) as a critical factor in panic disorders, a shift from traditional focuses like the amygdala. The LPBN, known for its roles in respiratory control and sensing internal bodily states, also significantly influences emotional and panic responses through its interactions with the amygdala and periaqueductal gray (PAG). Studies using pharmacological agents to induce panic in animals suggest that manipulating the LPBN can alleviate such behaviors, highlighting its potential as a therapeutic target for treating panic disorders due to its extensive neural connections and influence on physiological responses.

Therapeutic Implications and Future Directions
The involvement of the LPBN in panic disorders opens new avenues for targeted therapies. Localized and precise interventions, such as pharmacological agents designed to modulate LPBN activity or neuromodulation techniques, hold promise. These approaches align with the current trend in neuropsychiatry, which emphasizes specific, circuit-based treatments rather than generalized therapies.

Paradigm Shift in Understanding and Treating Panic Disorders
Highlighting the role of the LPBN rather than focusing solely on the amygdala represents a paradigm shift in understanding panic disorders. This broader perspective could enhance therapeutic efficacy by targeting multiple neural circuits involved in the disorder. Continued research is crucial, as a deeper understanding of the LPBN could lead to more effective treatments.

To solidify these findings, further literature reviews, experimental validation, and clinical trials are necessary. Exploring the LPBN’s role through ongoing or completed clinical trials targeting this brain region for panic disorder treatment is essential to translate these findings into clinical practice.

Conclusion
In summary, integrating current knowledge about the LPBN with new research directions holds significant potential for improving the understanding and treatment of panic disorders. While the evidence is promising, comprehensive literature reviews and expert consultations are essential to validate these new therapeutic targets. As research continues to evolve, so too will our strategies for combating this debilitating condition, with the LPBN playing a central role in these developments.

Dr. Terry McIvor is the founder of the International Guild of Hypnotherapy,NLP and 3 Principles Practitioners and Trainers. (IGH3P)

IGH3P is a professional development body which develops the skills of coaches, Hypnotherapist and NLPers.

He is an educationalist of over 20 years experience and has been accredited as a STEM and Science expert at level 6 and 7 by the Office of Qualifications and Examinations Regulation (OFQUAL) in the U.K.

Dr. Terry is also an NLP trainer, Master Hypnotist, a qualified Hypnotherapist and 3 Principles Coach.

He is trainer for most of the leading hypnosis professional bodies in the U.S including IACT, ICBCH,IMDHA, and the Elman Institute,

Dr. Terry has set up his own accredited STEM school in the U.K. called AISR, it is through his academy he conducts his teaching and research.

Learn more at www.IGH3P.com. You can email him at registrar@ig h3p.com

Connect with her through the social media:

Twitter/X – @IGH3P_

Facebook – www.facebook.com/TerryIGH3P

YouTube – https://www.youtube.com/@IGH3P

Instagram – https://www.instagram.com/igh3p_coach_accreditedtraining/

TikTok – https://www.tiktok.com/@igh3p?_t=8hRaTlXPM4f&_r=1, https://www.tiktok.com/@synaptictrainer?_t=8hRaaPYBY81&_r=1